The link you have selected will take you away from the TAVNEOS® (avacopan) website to one that is not owned or controlled by ChemoCentryx. ChemoCentryx accepts no responsibility for the content of linked sites.
The link you have selected will take you away from the TAVNEOS® (avacopan) website to the patient support program enrollment website
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click “OK” if you are a healthcare professional.
Based on your location, you are being redirected to the website of our licensee Vifor Fresenius Medical Care Renal Pharma Ltd. CCXI does not have responsibility for, or control of, the contents, availability, operation, or performance of the website.
TAVNEOS® (avacopan) is not a steroid. It is a targeted therapy that was designed to block a receptor involved inANCA-associated vasculitis.
TAVNEOS was studied in a clinical trial involving 330 adults living with ANCA-associated vasculitis over 52 weeks
*Immunosuppressive therapy: rituximab or cyclophosphamide followed by azathioprine
†Standard therapy: immunosuppressive therapy and a gradual reduction of prednisone over time
Talk to
your doctor
about adding TAVNEOS today
if you’re still
experiencing signs and
symptoms of
ANCA-associated
vasculitis.
The most common side effects are nausea, headache, high blood pressure, diarrhea, vomiting, rash, tiredness, stomach pain, dizziness, increase in blood creatinine, and burning or prickling sensation. However, these are not all of the possible side effects that may occur with TAVNEOS.
Do not take TAVNEOS if you are allergic to avacopan or any of the other ingredients of this medicine. See the Medication Guide for a complete list of the ingredients in TAVNEOS.
These could be signs of an allergic reaction. Do not take any more TAVNEOS until you have consulted with your healthcare provider.
TAVNEOS can cause serious side effects, including:
Your healthcare provider will do blood tests to check how well your liver is working before starting and during your treatment with TAVNEOS.
including prescription and over-the-counter medicines, vitamins, and herbal supplements. TAVNEOS and certain other medicines may affect each other and cause side effects. Keep a list of the medicines you take and show it to your healthcare provider and pharmacist.
The most common side effects of TAVNEOS include:
TAVNEOS is a prescription medicine that is used with other medicines (such as glucocorticoids) to treat adults with severe active anti-neutrophil cytoplasmic autoantibody(ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA], formerly known as Wegener’s granulomatosis, and microscopic polyangiitis [MPA]).
It is not known if TAVNEOS is safe and effective in children under the age of 18.
These are not all the possible side effects of TAVNEOS. Call your doctor for medical advice about side effects. Please see the Full Prescribing Information and Medication Guide for further details.
TAVNEOS is available as a 10 mg capsule.
You are encouraged to report negative side effects to 1-833-828-6367 or to the FDA by visiting www.fda.gov/medwatch or calling 1-800-332-1088.
IMPORTANT SAFETY INFORMATION
TAVNEOS can cause serious side effects, including:
TAVNEOS is a prescription medicine that is used with other medicines (such as glucocorticoids) to treat adults with severe active